200 related articles for article (PubMed ID: 27730398)
1. Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality.
Denbo JW; Bruno ML; Cloyd JM; Prakash L; Lee JE; Kim M; Crane CH; Koay EJ; Krishnan S; Das P; Minsky BD; Varadhachary G; Shroff R; Wolff R; Javle M; Overman MJ; Fogelman D; Aloia TA; Vauthey JN; Fleming JB; Katz MH
J Gastrointest Surg; 2016 Dec; 20(12):1975-1985. PubMed ID: 27730398
[TBL] [Abstract][Full Text] [Related]
2. Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis.
Araujo RL; Gaujoux S; Huguet F; Gonen M; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Jarnagin WR; Goodman KA; Allen PJ
HPB (Oxford); 2013 Aug; 15(8):574-80. PubMed ID: 23458208
[TBL] [Abstract][Full Text] [Related]
3. Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation or stereotactic body radiation therapy.
Blair AB; Rosati LM; Rezaee N; Gemenetzis G; Zheng L; Hruban RH; Cameron JL; Weiss MJ; Wolfgang CL; Herman JM; He J
Surgery; 2018 May; 163(5):1090-1096. PubMed ID: 29395234
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma.
Takahashi H; Ogawa H; Ohigashi H; Gotoh K; Yamada T; Ohue M; Miyashiro I; Noura S; Kishi K; Motoori M; Shingai T; Nakamura S; Nishiyama K; Yano M; Ishikawa O
Surgery; 2011 Sep; 150(3):547-56. PubMed ID: 21621236
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic adenocarcinoma: effects of neoadjuvant therapy on post-pancreatectomy outcomes - an American College of Surgeons National Surgical Quality Improvement Program targeted variable review.
Czosnyka NM; Borgert AJ; Smith TJ
HPB (Oxford); 2017 Oct; 19(10):927-932. PubMed ID: 28747265
[TBL] [Abstract][Full Text] [Related]
6. Preoperative chemotherapy does not adversely affect pancreatic structure and short-term outcome after pancreatectomy.
Pecorelli N; Braga M; Doglioni C; Balzano G; Reni M; Cereda S; Albarello L; Castoldi R; Capretti G; Di Carlo V
J Gastrointest Surg; 2013 Mar; 17(3):488-93. PubMed ID: 23132627
[TBL] [Abstract][Full Text] [Related]
7. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a nationwide analysis.
Wismans LV; Suurmeijer JA; van Dongen JC; Bonsing BA; Van Santvoort HC; Wilmink JW; van Tienhoven G; de Hingh IH; Lips DJ; van der Harst E; de Meijer VE; Patijn GA; Bosscha K; Stommel MW; Festen S; den Dulk M; Nuyttens JJ; Intven MPW; de Vos-Geelen J; Molenaar IQ; Busch OR; Koerkamp BG; Besselink MG; van Eijck CHJ;
Surgery; 2024 Jun; 175(6):1580-1586. PubMed ID: 38448277
[TBL] [Abstract][Full Text] [Related]
9. Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01).
Hayashi T; Nakamura T; Kimura Y; Yoshida M; Someya M; Kawakami H; Sakuhara Y; Katoh N; Takahashi K; Ambo Y; Miura K; Motoya M; Tanaka E; Murakawa K; Yamabuki T; Yamazaki H; Katanuma A; Hirano S;
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):606-617. PubMed ID: 31306735
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for postoperative pancreatic fistula following non-traumatic, pancreatic surgery. Retrospective observational study.
Mostafa A; Habeeb TA; Neri V; Elshahidy TM; A Fiad A
Ann Ital Chir; 2023; 94():435-442. PubMed ID: 38051507
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.
Marchegiani G; Andrianello S; Nessi C; Sandini M; Maggino L; Malleo G; Paiella S; Polati E; Bassi C; Salvia R
Ann Surg Oncol; 2018 Mar; 25(3):626-637. PubMed ID: 29214453
[TBL] [Abstract][Full Text] [Related]
12. Distal pancreatectomy for pancreatic carcinoma in the era of multimodal treatment.
Paye F; Micelli Lupinacci R; Bachellier P; Boher JM; Delpero JR;
Br J Surg; 2015 Feb; 102(3):229-36. PubMed ID: 25533421
[TBL] [Abstract][Full Text] [Related]
13. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study.
Klompmaker S; van Hilst J; Gerritsen SL; Adham M; Teresa Albiol Quer M; Bassi C; Berrevoet F; Boggi U; Busch OR; Cesaretti M; Dalla Valle R; Darnis B; De Pastena M; Del Chiaro M; Grützmann R; Diener MK; Dumitrascu T; Friess H; Ivanecz A; Karayiannakis A; Fusai GK; Labori KJ; Lombardo C; López-Ben S; Mabrut JY; Niesen W; Pardo F; Perinel J; Popescu I; Roeyen G; Sauvanet A; Prasad R; Sturesson C; Lesurtel M; Kleeff J; Salvia R; Besselink MG;
Ann Surg Oncol; 2018 May; 25(5):1440-1447. PubMed ID: 29532342
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Radiation Is Associated with Fistula Formation Following Pancreaticoduodenectomy.
Zettervall SL; Ju T; Holzmacher JL; Rivas L; Lin PP; Vaziri K
J Gastrointest Surg; 2018 Jun; 22(6):1026-1033. PubMed ID: 29500685
[TBL] [Abstract][Full Text] [Related]
15. High risk pathogens and risk factors for postoperative pancreatic fistula after pancreatectomy; a retrospective case-controlled study.
Abe K; Kitago M; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Yokose T; Endo Y; Kitagawa Y
Int J Surg; 2020 Oct; 82():136-142. PubMed ID: 32861892
[TBL] [Abstract][Full Text] [Related]
16. Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis.
Mangieri CW; Strode MA; Moaven O; Clark CJ; Shen P
J Surg Oncol; 2020 Dec; 122(8):1604-1611. PubMed ID: 32935353
[TBL] [Abstract][Full Text] [Related]
17. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.
Downs-Canner S; Ding Y; Magge DR; Jones H; Ramalingam L; Zureikat A; Holtzman M; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2015 May; 22(5):1651-7. PubMed ID: 25348781
[TBL] [Abstract][Full Text] [Related]
19. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Cloyd JM; Crane CH; Koay EJ; Das P; Krishnan S; Prakash L; Snyder RA; Varadhachary GR; Wolff RA; Javle M; Shroff RT; Fogelman D; Overman M; Wang H; Maitra A; Lee JE; Fleming JB; Katz MH
Cancer; 2016 Sep; 122(17):2671-9. PubMed ID: 27243381
[TBL] [Abstract][Full Text] [Related]
20. Do Drains Contribute to Pancreatic Fistulae? Analysis of over 5000 Pancreatectomy Patients.
El Khoury R; Kabir C; Maker VK; Banulescu M; Wasserman M; Maker AV
J Gastrointest Surg; 2018 Jun; 22(6):1007-1015. PubMed ID: 29435899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
